Bradykinin promotes vascular endothelial growth factor expression and increases angiogenesis in human prostate cancer cells

Biochemical Pharmacology

Volumn 87, Issue 2, 2014, Pages 243-253

  Yu, Hsin Shan ^a   Wang, Shih Wei ^b   Chang, An Chen ^a   Tai, Huai Ching ^c,d   Yeh, Hung I ^b,e   Lin, Yu Min ^f,g   Tang, Chih Hsin ^a,h,i  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b MACKAY MEDICAL COLLEGE   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e MACKAY MEMORIAL HOSPITAL   (Taiwan)

^f CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^g TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^h CHINA MEDICAL UNIVERSITY   (Taiwan)

ⁱ ASIA UNIVERSITY   (Taiwan)

Author keywords

Angiogenesis; Bradykinin; Prostate cancer; VEGF

Indexed keywords

BRADYKININ; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN KINASE B; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR AP 1; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CANCER CELL; CARCINOGENESIS; CELL FUNCTION; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; MALE; METASTASIS; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROTEIN EXPRESSION; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION;

ANGIOGENESIS; BRADYKININ; PROSTATE CANCER; VEGF;

BRADYKININ; CELLS, CULTURED; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MALE; NEOVASCULARIZATION, PATHOLOGIC; PROSTATIC NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84892372034     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2013.10.016     Document Type: Article

References (48)

1. T.L. Veveris-Lowe, M.G. Lawrence, R.L. Collard, L. Bui, A.C. Herington, and D.L. Nicol et al. Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells Endocr Relat Cancer 12 2005 631 643 (Pubitemid 41482997)
2. G.G. Giles, G. Severi, D.R. English, M.R. McCredie, R. Borland, and P. Boyle et al. Sexual factors and prostate cancer BJU Int 92 2003 211 216 (Pubitemid 36966579)
3. A.F. Chambers, A.C. Groom, and I.C. MacDonald Dissemination and growth of cancer cells in metastatic sites Nat Rev Cancer 2 2002 563 572 (Pubitemid 37328923)
4. N.M. Pandya, N.S. Dhalla, and D.D. Santani Angiogenesis - a new target for future therapy Vascul Pharmacol 44 2006 265 274
5. G. McMahon VEGF receptor signaling in tumor angiogenesis Oncologist 5 Suppl 1 2000 3 10 (Pubitemid 30225450)
6. P. Carmeliet, and R.K. Jain Angiogenesis in cancer and other diseases Nature 407 2000 249 257
7. A.M. Keating, and D.S. Jacobs Anti-VEGF treatment of corneal neovascularization Ocul Surf 9 2011 227 237
8. P. Carmeliet VEGF as a key mediator of angiogenesis in cancer Oncology 69 Suppl. 3 2005 4 10 (Pubitemid 41680947)
9. S.M. Weis, and D.A. Cheresh Tumor angiogenesis: molecular pathways and therapeutic targets Nat Med 17 2011 1359 1370
10. J. Wu, T. Akaike, and H. Maeda Modulation of enhanced vascular permeability in tumors by a bradykinin antagonist, a cyclooxygenase inhibitor, and a nitric oxide scavenger Cancer Res 58 1998 159 165 (Pubitemid 28027731)
11. J. Wu, T. Akaike, K. Hayashida, T. Okamoto, A. Okuyama, and H. Maeda Enhanced vascular permeability in solid tumor involving peroxynitrite and matrix metalloproteinases Jpn J Cancer Res: Gann 92 2001 439 451 (Pubitemid 32427781)
12. H.S. Yu, T.H. Lin, and C.H. Tang Involvement of intercellular adhesion molecule-1 up-regulation in bradykinin promotes cell motility in human prostate cancers Int J Mol Sci 14 2013 13329 13345
13. D. Regoli, and J. Barabe Pharmacology of bradykinin and related kinins Pharmacol Rev 32 1980 1 46
14. J.G. Menke, J.A. Borkowski, K.K. Bierilo, T. MacNeil, A.W. Derrick, and K.A. Schneck et al. Expression cloning of a human B1 bradykinin receptor J Biol Chem 269 1994 21583 21586 (Pubitemid 24274792)
15. L. Molina, C.E. Matus, A. Astroza, F. Pavicic, E. Tapia, and C. Toledo et al. Stimulation of the bradykinin B(1) receptor induces the proliferation of estrogen-sensitive breast cancer cells and activates the ERK1/2 signaling pathway Breast Cancer Res Treat 118 2009 499 510
16. V. Montana, and H. Sontheimer Bradykinin promotes the chemotactic invasion of primary brain tumors J Neurosci 31 2011 4858 4867
17. W.H. Yang, J.T. Chang, S.F. Hsu, T.M. Li, D.Y. Cho, and C.Y. Huang et al. Bradykinin enhances cell migration in human chondrosarcoma cells through BK receptor signaling pathways J Cell Biochem 109 2010 82 92
18. D. Vassou, G. Notas, A. Hatzoglou, E. Castanas, and M. Kampa Opioids increase bladder cancer cell migration via bradykinin B2 receptors Int J Oncol 39 2011 697 707
19. C.H. Lee, D.C. Shieh, C.Y. Tzeng, C.P. Chen, S.P. Wang, and Y.C. Chiu et al. Bradykinin-induced IL-6 expression through bradykinin B2 receptor, phospholipase C, protein kinase Cdelta and NF-kappaB pathway in human synovial fibroblasts Mol Immunol 45 2008 3693 3702
20. A. Carracedo, and P.P. Pandolfi The PTEN-PI3K pathway: of feedbacks and cross-talks Oncogene 27 2008 5527 5541
21. I. Vivanco, and C.L. Sawyers The phosphatidylinositol 3-kinase AKT pathway in human cancer Nat Rev Cancer 2 2002 489 501 (Pubitemid 37328931)
22. M.A. Frias, C.C. Thoreen, J.D. Jaffe, W. Schroder, T. Sculley, and S.A. Carr et al. mSin1 is necessary for Akt/PKB phosphorylation, and its isoforms define three distinct mTORC2s Curr Biol 16 2006 1865 1870 (Pubitemid 44354144)
23. E. Jacinto, V. Facchinetti, D. Liu, N. Soto, S. Wei, and S.Y. Jung et al. SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity Cell 127 2006 125 137 (Pubitemid 44466632)
24. G.Y. Li, K.H. Jung, H. Lee, M.K. Son, J. Seo, and S.W. Hong et al. A novel imidazopyridine derivative, HS-106, induces apoptosis of breast cancer cells and represses angiogenesis by targeting the PI3K/mTOR pathway Cancer Lett 329 2013 59 67
25. D. Sarker, A.H. Reid, T.A. Yap, and J.S. de Bono Targeting the PI3K/AKT pathway for the treatment of prostate cancer Clin Cancer Res: Off J Am Assoc Cancer Res 15 2009 4799 4805
26. A. Bishayee, and A.S. Darvesh Angiogenesis in hepatocellular carcinoma: a potential target for chemoprevention and therapy Curr Cancer Drug Targets 12 2012 1095 1118
27. A. Albini, F. Tosetti, V.W. Li, D.M. Noonan, and W.W. Li Cancer prevention by targeting angiogenesis Nat Rev Clin Oncol 9 2012 498 509
28. N. Ferrara VEGF and the quest for tumour angiogenesis factors Nat Rev Cancer 2 2002 795 803 (Pubitemid 37328914)
29. Y. Ikeda, I. Hayashi, E. Kamoshita, A. Yamazaki, H. Endo, and K. Ishihara et al. Host stromal bradykinin B2 receptor signaling facilitates tumor-associated angiogenesis and tumor growth Cancer Res 64 2004 5178 5185 (Pubitemid 39006536)
30. C.H. Tang, C.J. Hsu, and Y.C. Fong The CCL5/CCR5 axis promotes interleukin-6 production in human synovial fibroblasts Arthritis Rheum 62 2010 3615 3624
31. T.C. Hsia, C.Y. Tu, Y.J. Chen, Y.L. Wei, M.C. Yu, and S.C. Hsu et al. Lapatinib-mediated cyclooxygenase-2 expression via epidermal growth factor receptor/HuR interaction enhances the aggressiveness of triple-negative breast cancer cells Mol Pharmacol 83 2013 857 869
32. C.H. Chung, C.H. Chang, S.S. Chen, H.H. Wang, J.Y. Yen, and C.J. Hsiao et al. Butein inhibits angiogenesis of human endothelial progenitor cells via the translation dependent signaling pathway Evid Based Complement Altern Med 2013 2013 943187
33. H.H. Wang, C.H. Su, Y.J. Wu, J.Y. Li, Y.M. Tseng, and Y.C. Lin et al. Reduction of connexin43 in human endothelial progenitor cells impairs the angiogenic potential Angiogenesis 16 2013 553 560
34. C.Y. Huang, S.Y. Chen, H.C. Tsai, H.C. Hsu, and C.H. Tang Thrombin induces epidermal growth factor receptor transactivation and CCL2 expression in human osteoblasts Arthritis Rheum 64 2012 3344 3354
35. C.H. Tang, and M.E. Lu Adiponectin increases motility of human prostate cancer cells via adipoR, p38, AMPK, and NF-kappaB pathways Prostate 69 2009 1781 1789
36. H.S. Yu, T.H. Lin, and C.H. Tang Bradykinin enhances cell migration in human prostate cancer cells through B2 receptor/PKCdelta/c-Src dependent signaling pathway Prostate 73 2013 89 100
37. G. Bergers, and L.E. Benjamin Tumorigenesis and the angiogenic switch Nat Rev Cancer 3 2003 401 410 (Pubitemid 37328844)
38. D. Morgensztern, and H.L. McLeod PI3K/Akt/mTOR pathway as a target for cancer therapy Anticancer Drugs 16 2005 797 803 (Pubitemid 41215743)
39. Y. Yin, S. Wang, Y. Sun, Y. Matt, N.H. Colburn, and Y. Shu et al. JNK/AP-1 pathway is involved in tumor necrosis factor-alpha induced expression of vascular endothelial growth factor in MCF7 cells Biomed Pharmacother 63 2009 429 435
40. A. Jemal, R. Siegel, J. Xu, and E. Ward Cancer statistics, 2010 CA: Cancer J Clin 60 2010 277 300
41. M. Maurer, M. Bader, M. Bas, F. Bossi, M. Cicardi, and M. Cugno et al. New topics in bradykinin research Allergy 66 2011 1397 1406
42. C.Y. Cheng, C.T. Kuo, C.C. Lin, H.L. Hsieh, and C.M. Yang IL-1beta induces expression of matrix metalloproteinase-9 and cell migration via a c-Src-dependent, growth factor receptor transactivation in A549 cells Br J Pharmacol 160 2010 1595 1610
43. J.M. Hall Bradykinin receptors Gen Pharmacol 28 1997 1 6 (Pubitemid 27016051)
44. J. Fang, M. Ding, L. Yang, L.Z. Liu, and B.H. Jiang PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis Cell Signal 19 2007 2487 2497 (Pubitemid 47531929)
45. J. Kang, P.G. Rychahou, T.A. Ishola, J.M. Mourot, B.M. Evers, and D.H. Chung N-myc is a novel regulator of PI3K-mediated VEGF expression in neuroblastoma Oncogene 27 2008 3999 4007 (Pubitemid 351913633)
46. L. He, Y. Wu, L. Lin, J. Wang, Y. Chen, and Z. Yi et al. Hispidulin, a small flavonoid molecule, suppresses the angiogenesis and growth of human pancreatic cancer by targeting vascular endothelial growth factor receptor 2-mediated PI3K/Akt/mTOR signaling pathway Cancer Sci 102 2011 219 225
47. K. Shen, L. Ji, C. Gong, Y. Ma, L. Yang, and Y. Fan et al. Notoginsenoside Ft1 promotes angiogenesis via HIF-1alpha mediated VEGF secretion and the regulation of PI3K/AKT and Raf/MEK/ERK signaling pathways Biochem Pharmacol 84 2012 784 792
48. L. Bubendorf, A. Schopfer, U. Wagner, G. Sauter, H. Moch, and N. Willi et al. Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients Human Pathol 31 2000 578 583 (Pubitemid 30323983)